microdosing semaglutide benefits I Microdosed at 0.1 mg Weekly for 6 Months — Here's What Actually Happened GLP-1 Microdosing 2026: 0.1mg Chart

South Dak

It has not received marketing authorisation from the MHRA, the EMA, or the US Food and Drug Administration (FDA), and therefore cannot be legally prescribed or dispensed outside of authorised clinical research settings

Only when Eli Lilly began testing dual GLP-1/GIP agonists did the picture change dramatically

Landing page copy

Lower Blood Pressure: Some GLP-1 receptor agonists, like semaglutide and liraglutide, have also been shown to reduce blood pressure, offering an added benefit for individuals managing both high blood pressure and diabetes

Its crucial to remember that these side effects are rare and might not necessarily be linked to the medication